Literature DB >> 11424630

Day-to-day variability of maximum walking distance in MS patients can mislead to relevant changes in the Expanded Disability Status Scale (EDSS): average walking speed is a more constant parameter.

H Albrecht1, C Wötzel, L P Erasmus, M Kleinpeter, N König, W Pöllmann.   

Abstract

In this preliminary study we measured maximum walking distance and walking time on four consecutive days in 29 patients with clinically stable multiple sclerosis (MS). Patients were included in the study if they could achieve a maximum unaided walking distance of 100 up to 500 m. Our results showed a certain day-to-day variability of maximum walking distance, in some cases meaning changes up to 1.5 points in the expanded disability status scale (EDSS), which could be misinterpreted as a progression of the disease. Simultaneous measurements of maximum walking time showed a similar variability, unlike the mean walking speed which turned out to be more stable. Our results therefore suggest that scoring of MS patients should not be based on one single measurement of the maximum walking distance. The more reliable parameter appears to be the mean walking speed.

Entities:  

Mesh:

Year:  2001        PMID: 11424630     DOI: 10.1177/135245850100700206

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  23 in total

1.  Estimates of the walking distance in multiple sclerosis patients and their effect on the EDSS.

Authors:  Isabel Ringel; U K Zettl
Journal:  J Neurol       Date:  2006-04-20       Impact factor: 4.849

2.  Evaluating walking in patients with multiple sclerosis: which assessment tools are useful in clinical practice?

Authors:  Francois Bethoux; Susan Bennett
Journal:  Int J MS Care       Date:  2011

3.  Disease mechanisms in MS: phases of disease improvement unrelated to relapses.

Authors:  Oluf Andersen
Journal:  Nat Rev Neurol       Date:  2012-09-11       Impact factor: 42.937

4.  The MoSt Project--more steps in multiple sclerosis: a Delphi method consensus initiative for the evaluation of mobility management of MS patients in Italy.

Authors:  Ruggero Capra; Mario Alberto Battaglia; Antonio Gaudioso; Laura Lopes; Damiano Paolicelli; Marco Paoloni; Carlo Pozzilli; Valter Santilli; Claudio Solaro; Maria Trojano
Journal:  J Neurol       Date:  2014-01-22       Impact factor: 4.849

Review 5.  What We Learned from The History of Multiple Sclerosis Measurement: Expanded Disability Status Scale.

Authors:  Bilge Piri Çinar; Yüksel Güven Yorgun
Journal:  Noro Psikiyatr Ars       Date:  2018       Impact factor: 1.339

Review 6.  Performance and Capacity Measurement of the Lower Extremities in Multiple Sclerosis -How to Approach?

Authors:  Sıla Usar İncirli; Özlem Taşkapilioğlu
Journal:  Noro Psikiyatr Ars       Date:  2018       Impact factor: 1.339

7.  Treatment of walking impairment in multiple sclerosis with dalfampridine.

Authors:  Andrew R Blight
Journal:  Ther Adv Neurol Disord       Date:  2011-03       Impact factor: 6.570

8.  Validity and Reliability of Four Clinical Gait Measures in Patients with Multiple Sclerosis.

Authors:  Susan E Bennett; Lacey E Bromley; Nadine M Fisher; Machiko R Tomita; Paulette Niewczyk
Journal:  Int J MS Care       Date:  2017 Sep-Oct

Review 9.  Predicting responders to therapies for multiple sclerosis.

Authors:  Jordi Río; Manuel Comabella; Xavier Montalban
Journal:  Nat Rev Neurol       Date:  2009-10       Impact factor: 42.937

10.  Potential of Timed 25-Foot Walk Values in Predicting Maximum Walking Distance in Persons with Multiple Sclerosis.

Authors:  Foziah Alshamrani; Warren Berger; Hind Alnajashi; Michael W C Payne; Sarah A Morrow
Journal:  Int J MS Care       Date:  2020-01-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.